Winston Pharmaceuticals, Inc.
WPHM
$0.00
$0.000.00%
| 03/31/2010 | 12/31/2009 | 09/30/2009 | 06/30/2009 | 03/31/2009 | |
|---|---|---|---|---|---|
| Revenue | 316.70K | 339.00K | 350.50K | 365.00K | 340.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 316.70K | 339.00K | 350.50K | 365.00K | 340.00K |
| Cost of Revenue | 326.30K | 346.30K | 582.90K | 587.80K | 546.00K |
| Gross Profit | -9.60K | -7.20K | -232.40K | -222.70K | -206.00K |
| SG&A Expenses | 449.80K | 552.80K | 468.10K | 462.70K | 580.30K |
| Depreciation & Amortization | 2.10K | 2.20K | 2.20K | 2.30K | 2.30K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 778.20K | 901.20K | 1.05M | 1.05M | 1.13M |
| Operating Income | -461.50K | -562.20K | -702.70K | -687.70K | -788.60K |
| Income Before Tax | -460.70K | -561.90K | -702.50K | -612.10K | -778.80K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -460.70K | -561.90K | -702.50K | -612.10K | -778.80K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -460.70K | -561.90K | -702.50K | -612.10K | -778.80K |
| EBIT | -461.50K | -562.20K | -702.70K | -687.70K | -788.60K |
| EBITDA | -459.40K | -560.00K | -700.50K | -685.40K | -786.30K |
| EPS Basic | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| Normalized Basic EPS | 0.00 | 0.00 | -0.01 | -0.01 | -0.01 |
| EPS Diluted | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| Normalized Diluted EPS | 0.00 | 0.00 | -0.01 | -0.01 | -0.01 |
| Average Basic Shares Outstanding | 77.41M | 77.58M | 56.69M | 55.44M | 55.31M |
| Average Diluted Shares Outstanding | 77.41M | 77.58M | 56.69M | 55.44M | 55.31M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
